Simon Frachet, Pauline Chazelas, Laurent Magy, Pascal Cintas, Danielle Brouquières, Pierre Girardie, Louise Espagno, Boris Melloni, Laurent Guilleminault, Anne-Sophie Lia
{"title":"RFC1 内扩张患者咳嗽时的早期周围神经受累。","authors":"Simon Frachet, Pauline Chazelas, Laurent Magy, Pascal Cintas, Danielle Brouquières, Pierre Girardie, Louise Espagno, Boris Melloni, Laurent Guilleminault, Anne-Sophie Lia","doi":"10.1212/NXG.0000000000200166","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome results from variations in <i>RFC1</i> and is mostly caused by intronic biallelic pathogenic expansions (RE-<i>RFC1</i>). Refractory chronic cough (RCC) is frequently observed for years to decades preceding ataxia onset. Whether peripheral nerves are involved in the presymptomatic phase characterized by RCC is uncertain.</p><p><strong>Methods: </strong>Here, patients previously screened for RCC and identified as having at least one RE-<i>RFC1</i> intronic expansion underwent a comprehensive clinical and neurophysiologic assessment and were screened for additional exonic variations.</p><p><strong>Results: </strong>Fourteen patients with RCC and RE-<i>RFC1</i> were investigated. Seven patients presented with biallelic RE-<i>RFC1</i> (Bi-RE-<i>RFC1</i>) while 7 presented with monoallelic RE-<i>RFC1</i> (Mono-RE-<i>RFC1</i>). In patients with Mono-RE-<i>RFC1</i>, no additional exonic variation was identified, and clinical examinations were normal. Most of the patients with Bi-RE-<i>RFC1</i> presented with subtle neurologic impairment, mainly exhibiting decreased lower limb vibration sense (85.7%). Nerve conduction studies revealed that all patients with Bi-RE-<i>RFC1</i> exhibited lower sensory sum scores than patients with Mono-RE-<i>RFC1</i> (median 20.2 µV vs 84.9 µV, <i>p</i> = 0.0012). In addition, the radial-to-sural sensory ratios were null or inverted (>0.5) in all patients but one with Bi-RE-<i>RFC1</i>, which is consistent with sensory neuronopathy.</p><p><strong>Discussion: </strong>Patients with Bi-RE-RFC1 already exhibit widespread sensory neuron involvement at the time of apparently isolated RCC.</p>","PeriodicalId":48613,"journal":{"name":"Neurology-Genetics","volume":"10 4","pages":"e200166"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11271393/pdf/","citationCount":"0","resultStr":"{\"title\":\"Early Peripheral Nerve Involvement at the Time of Coughing in Patients With <i>RFC1</i> Intronic Expansion.\",\"authors\":\"Simon Frachet, Pauline Chazelas, Laurent Magy, Pascal Cintas, Danielle Brouquières, Pierre Girardie, Louise Espagno, Boris Melloni, Laurent Guilleminault, Anne-Sophie Lia\",\"doi\":\"10.1212/NXG.0000000000200166\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome results from variations in <i>RFC1</i> and is mostly caused by intronic biallelic pathogenic expansions (RE-<i>RFC1</i>). Refractory chronic cough (RCC) is frequently observed for years to decades preceding ataxia onset. Whether peripheral nerves are involved in the presymptomatic phase characterized by RCC is uncertain.</p><p><strong>Methods: </strong>Here, patients previously screened for RCC and identified as having at least one RE-<i>RFC1</i> intronic expansion underwent a comprehensive clinical and neurophysiologic assessment and were screened for additional exonic variations.</p><p><strong>Results: </strong>Fourteen patients with RCC and RE-<i>RFC1</i> were investigated. Seven patients presented with biallelic RE-<i>RFC1</i> (Bi-RE-<i>RFC1</i>) while 7 presented with monoallelic RE-<i>RFC1</i> (Mono-RE-<i>RFC1</i>). In patients with Mono-RE-<i>RFC1</i>, no additional exonic variation was identified, and clinical examinations were normal. Most of the patients with Bi-RE-<i>RFC1</i> presented with subtle neurologic impairment, mainly exhibiting decreased lower limb vibration sense (85.7%). Nerve conduction studies revealed that all patients with Bi-RE-<i>RFC1</i> exhibited lower sensory sum scores than patients with Mono-RE-<i>RFC1</i> (median 20.2 µV vs 84.9 µV, <i>p</i> = 0.0012). In addition, the radial-to-sural sensory ratios were null or inverted (>0.5) in all patients but one with Bi-RE-<i>RFC1</i>, which is consistent with sensory neuronopathy.</p><p><strong>Discussion: </strong>Patients with Bi-RE-RFC1 already exhibit widespread sensory neuron involvement at the time of apparently isolated RCC.</p>\",\"PeriodicalId\":48613,\"journal\":{\"name\":\"Neurology-Genetics\",\"volume\":\"10 4\",\"pages\":\"e200166\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11271393/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology-Genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/NXG.0000000000200166\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology-Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXG.0000000000200166","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Early Peripheral Nerve Involvement at the Time of Coughing in Patients With RFC1 Intronic Expansion.
Objectives: Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome results from variations in RFC1 and is mostly caused by intronic biallelic pathogenic expansions (RE-RFC1). Refractory chronic cough (RCC) is frequently observed for years to decades preceding ataxia onset. Whether peripheral nerves are involved in the presymptomatic phase characterized by RCC is uncertain.
Methods: Here, patients previously screened for RCC and identified as having at least one RE-RFC1 intronic expansion underwent a comprehensive clinical and neurophysiologic assessment and were screened for additional exonic variations.
Results: Fourteen patients with RCC and RE-RFC1 were investigated. Seven patients presented with biallelic RE-RFC1 (Bi-RE-RFC1) while 7 presented with monoallelic RE-RFC1 (Mono-RE-RFC1). In patients with Mono-RE-RFC1, no additional exonic variation was identified, and clinical examinations were normal. Most of the patients with Bi-RE-RFC1 presented with subtle neurologic impairment, mainly exhibiting decreased lower limb vibration sense (85.7%). Nerve conduction studies revealed that all patients with Bi-RE-RFC1 exhibited lower sensory sum scores than patients with Mono-RE-RFC1 (median 20.2 µV vs 84.9 µV, p = 0.0012). In addition, the radial-to-sural sensory ratios were null or inverted (>0.5) in all patients but one with Bi-RE-RFC1, which is consistent with sensory neuronopathy.
Discussion: Patients with Bi-RE-RFC1 already exhibit widespread sensory neuron involvement at the time of apparently isolated RCC.
期刊介绍:
Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.